Latest news
TriSalus Life Sciences Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 17:04:15 GMTTriSalus Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Thu, 06 Aug 2026 22:42:30 GMTTLSI: Q2 revenue rose to $11.4M, with expanded OBL reimbursement and strong growth outlook - TradingViewTradingView · Thu, 06 Aug 2026 21:36:50 GMTTriSalus Life Sciences, Inc. 2026: Revenue $11.41M, EPS ($0.16) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTTLSI: Gross margin rose to 86.8% as sales held steady and liquidity improved with a $42.6M offering - TradingViewTradingView · Thu, 06 Aug 2026 20:05:48 GMTTLSI: Q2 revenue up 1.7% to $11.4M, gross margin 88%, and 2026 guidance reaffirmed at $54–$57M - TradingViewTradingView · Thu, 06 Aug 2026 20:03:40 GMTTLSI Q2'26 Earnings: EPS estimate is (0.15) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:41 GMT